Associate Professor of Medicine, Associate Professor of Oncology, Johns Hopkins University School of Medicine
Endocrinology
Dr. Douglas W. Ball, MD
|
|
Give Review
Douglas W. Ball is an expert in the field of Endocrinology. He researched medicine at George Washington University School of Medicine. George Washington University School of Medicine is ranked 67 in research and 0 in primary care medicine He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Douglas W. Ball, MD is a published doctor and has 63 publications published. The lastest was: 'Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection.'
Publications
- Misidentification of Putative Medullary Thyroid Cancer Cell Lines RO-H85-1 and RO-D81-1.
- Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS.
- Synergistic action of a RAF inhibitor and a dual PI-3 Kinase / mTOR inhibitor in Thyroid cancer.
- Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung.
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer.
- Incidentally discovered medullary Thyroid cancer: diagnostic strategies and treatment.
- Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic Cancer formation and progression through the suppression of Ras-Ral signaling.
- Selectively targeting mutant BRAF in Thyroid cancer.
- Dual inhibition of mitogen-activated protein kinase kinase and mammalian target of rapamycin in differentiated and anaplastic Thyroid cancer.
- American Thyroid Association guidelines for management of medullary Thyroid cancer: an adult endocrinology perspective.
- NCCN task force: clinical utility of PET in a variety of tumor Types.
- Achaete-scute complex homologue 1 regulates Tumor-initiating capacity in human small cell lung cancer.
- Selective growth inhibition in BRAF mutant Thyroid cancer by the mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244.
- Medullary Thyroid cancer: monitoring and therapy.
- Medullary Thyroid cancer: therapeutic targets and molecular markers.
- Unusual case of metastatic neuroEndocrine tumor.
- Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate Cancer cells.
- Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary Thyroid cancer.
- Regulation of neuroEndocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.
- Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary Thyroid carcinoma cells.
- GDNF-induced leukemia inhibitory factor can mediate differentiation via the MEK/ERK pathway in Pheochromocytoma cells derived from nf1-heterozygous knockout mice.
- Notch in lung development and lung Cancer.
- CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary Thyroid carcinoma cell growth.
- Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic Tumorigenesis.
- The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
- Notch signaling induces rapid degradation of achaete-scute homolog 1.
- Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 Syndromes.
- Cytogenetic studies of long-term survivors of childhood acute lymphoblastic leukemia.
- Identification of tibial stress fractures using therapeutic continuous ultrasound.
- A concise genetic and clinical guide to multiple endocrine neoplasias and related Syndromes.
- Case of an ivory vertebra.
- Robot-assisted cortical-sparing Adrenalectomy in a patient with Von Hippel-Lindau disease and bilateral pheochromocytomas separated by 9 years.
- Treatment of advanced medullary Thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
- Pathobiology of the C-cells.
- Cell-substratum interactions mediate oncogene-induced phenoType of lung cancer cells.
- Notch1 and notch2 have opposite effects on embryonal brain Tumor growth.
- Pathology forum: quiz case 1. Early medullary thyroid carcinoma (MTC), familial Type, arising in a background of C-cell hyperplasia.
- Human calcitonin gene regulation by helix-loop-helix recognition sequences.
- Regulation of human calcitonin gene transcription by cyclic AMP.
- Management of medullary Thyroid cancer.
- Cloning and chromosomal localization of the human BARX2 homeobox protein gene.
- Mammalian Scratch participates in neuronal differentiation in P19 embryonal carcinoma cells.
- Mammalian Scratch: a neural-specific Snail family transcriptional repressor.
- Effective long-term palliation of Symptomatic, incurable metastatic medullary thyroid cancer by operative resection.
- Molecular abnormalities in tumors associated with multiple endocrine neoplasia Type 2.
- Roles of trk family neurotrophin receptors in medullary Thyroid carcinoma development and progression.
- RET proto-oncogene mutations in inherited and sporadic medullary Thyroid cancer.
- Morphometric analysis of CC10-hASH1 transgenic mouse lung: a model for bronchiolization of alveoli and neuroEndocrine carcinoma.
- Combretastatin A-4 and doxorubicin combination treatment is effective in a preclinical model of human medullary Thyroid carcinoma.
- Differentiation of medullary Thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1.
- Identification of a human achaete-scute homolog highly expressed in neuroEndocrine tumors.
- Tissue-specific expression of human achaete-scute homologue-1 in neuroEndocrine tumors: transcriptional regulation by dual inhibitory regions.
- Conservation of the Drosophila lateral inhibition pathway in human lung Cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression.
- An achaete-scute homologue essential for neuroEndocrine differentiation in the lung.
- RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary Thyroid carcinomas.
- Notch signaling induces cell cycle arrest in small cell lung Cancer cells.
- Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroEndocrine tumors in transgenic mice.
- Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas.
- Achaete-scute homolog-1 and Notch in lung neuroEndocrine development and cancer.
- Notch in malignancy.
- Thyroid carcinoma.
- Medullary carcinoma.
Schools
George Washington University School of Medicine And Health Sciences
Johns Hopkins Hospital
University Health Center Of Pittsburgh
Conditions Treated
- Adrenal Incidentaloma
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- Craniopharyngioma
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice Advantage
- Blue Choice Network POS
- Blue Preferred PPO
- CareFirst Maryland POS
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Coventry Health Care of Delaware PPO
- Emblem Health
- Geisinger Health Plan
- Golden Rule
- GEHA
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- MedHealthInsurance
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- UniCare
- Choice Plus POS
- Navigate HMO
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Johns Hopkins University -
University of Pittsburgh Medical Center -
George Washington University School of Medicine
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1952366007 | |
| NPPES Provider LastName | BALL | |
| NPPES Provider FirstName | DOUGLAS | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 281.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952366007 |
| Last Name Of The Provider | BALL |
| First Name Of The Provider | DOUGLAS |
| View All |
Similar Doctors
|
|
Dr. Ari S. Eckman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela R. Schroeder VI, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marjorie A. Pennant, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer S. Mammen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie A. Stein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Asif A. Mohamed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arsalan Sheikh, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aniket R. Sidhaye, MD
This Doctor is OpenDoctor Recommended.
|